CX Institutional’s Parabilis Medicines Inc PBLS Stock Holding History

CX Institutional’s Portfolio PBLS Stock Details PBLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6K	Buy	+200	New	+$6.98K	﹤0.01%	1434

Other funds holding PBLS

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

CX Institutional's PBLS Position: Q3 2026 in Review

CX Institutional opened a new position in Parabilis Medicines Inc (PBLS) in Q3 2026: 200 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #1434 among its holdings.

6 funds tracked by Wall St. Rank hold PBLS as of Q3 2026.

CX Institutional held 200 shares of Parabilis Medicines Inc worth $6K as of Q3 2026.
Parabilis Medicines Inc was a new CX Institutional position in Q3 2026.
Parabilis Medicines Inc made up ﹤0.01% of CX Institutional's portfolio in Q3 2026, its #1434 holding.
6 funds tracked by Wall St. Rank held Parabilis Medicines Inc as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.